Last April an appellate team at Orrick, Herrington & Sutcliffe led by partners Josh Rosenkranz, Bob Loeb and Naomi Scotten landed the top runner-up spot for Litigator of the Week when they convinced a New Jersey appeals court to reverse a $117 million talcum powder verdict against Johnson & Johnson and Imerys Talc America. New Jersey’s Appellate Division found the trial judge shouldn’t have allowed two plaintiffs’ experts to testify at trial.

Fast forward a little more than a year and move the focus across the Hudson River: This week the Orrick appellate team scored another reversal for J&J. New York’s Appellate Division, First Department on Tuesday knocked out a $120 million damages award in a case brought on behalf of a Brooklyn woman who claimed J&J’s baby powder caused her cancer. The Manhattan appellate court found there wasn’t adequate evidence that the amount of asbestos the plaintiff claims she was exposed to was sufficient to cause her to develop mesothelioma.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]